ZICCUM
Ziccum is developing new dry-powder versions of the world’s most effective vaccines and biologic pharmaceuticals. These new, gently air-dried formulations can be transported easily and cost-effectively, with no costly cold storage or refrigeration required.
ZICCUM
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.ziccum.com
Total Employee:
1+
Status:
Active
Contact:
+46 709 61 55 99
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
HSTS Google Analytics 4 Person Schema Cloudflare JS CDN JS Gravatar Profiles ASP.NET IIS PostalAddress Schema IIS 10
Similar Organizations
Cobra Biologics
Cobra Biologics is providing a biologics and pharmaceuticals service.
Cristal Therapeutics
Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
KelSie Biotech
KelSie Biotech develops high bioavailability delivery methods to formulate and deliver sensitive active pharmaceutical ingredients.
Meshlin Composites
Meshlin trying to preserve the natural character of the materials and are to assure versatility and long life of our products.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Terraplasma
Terraplasma offers solutions for the development of cold plasma products in areas where germs or unwanted odours lead to problems.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Ziccum
Official Site Inspections
http://www.ziccum.com Semrush global rank: 11.11 M Semrush visits lastest month: 170
- Host name: tama.oderland.com
- IP address: 46.16.236.16
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Ziccum"
Ziccum successfully dries Biologics by Mass Transfer
Nov 20, 2024 Ziccum's unique drying and formulation system LaminarPace is a new way of drying biologics. It eliminates heat stress, heat degradation and the need for elevated temperatures. Unlike other pharmaceutical drying systems, …See details»
Ziccum Updates - Ziccum
Ziccum heads West in 2024 to J P Morgan Week & Longwood Healthcare Leaders CEO Conference Ziccum heads West in 2024, Jan 6 – 11, San Francisco. Book now to meet Ziccum and hear the latest news and data on …See details»
Ziccum - Crunchbase Company Profile & Funding
Ziccum focuses on drying mRNA/LNP, viral vectors using adenovirus, and subunit adjuvanted vaccines to improve their thermostability and administration routes. Novel Administration …See details»
Ziccum AB - LinkedIn
Ziccum CEO Ann Gidner, along with Business Manager Ilkim Atmaca, participated in Bio-Europe, held in Stockholm, Sweden from November 4–6, 2024.See details»
Ziccum Company Profile - Office Locations, Competitors ... - Craft
Ziccum is a company providing a technology that transforms vaccines, drugs, biologics, and chemicals into dry powders that can be transported and don't need temperature control. The …See details»
Ziccum AB (publ) (STO: ZICC) - Stock Analysis
Oct 29, 2024 Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid …See details»
Ziccum - ZICCUM AB - reports-en.ziccum.com
Ziccum has two main goals for 2021: to make concrete plans to establish a demonstration facility for Fill and Finish based on the LaminarPace technology, and to continue the work around out …See details»
Investor information - Ziccum
Jan 26, 2024 Ziccum AB is a Swedish public limited company governed by Swedish legislation, mainly the Swedish Companies Act (2005: 551) and the Swedish Annual Accounts Act (1995: …See details»
Ziccum - VentureRadar
Ziccum is developing new dry-powder versions of the world’s most effective vaccines and biologic pharmaceuticals. These new, gently air-dried formulations can be transported easily and cost …See details»
Ziccum - ZICCUM AB - reports-en.ziccum.com
Ziccum Interim Report Q2 2021 Ziccum in short. Ziccum's patented technology LaminarPace air-dries liquid vaccine into a thermostable powder vaccine. Before it is administered, the vaccine …See details»
Ziccum Company Profile 2024: Stock Performance & Earnings
Ziccum has 10 total employees. What industry is Ziccum in? Ziccum’s primary industry is Pharmaceuticals. Is Ziccum a private or public company? Ziccum is a Public company. What is …See details»
Ziccum AB, ZICC:STO profile - FT.com - Financial Times
Oct 18, 2024 Ziccum AB is a Sweden-based pharmaceutical company that is mainly engaged in developing vaccines. Ziccum develops new thermostable versions of vaccines and biologics …See details»
Ziccum - ZICCUM AB - reports-en.ziccum.com
Ziccum's shares were listed on Spotlight Stock Markets on October 25, 2018. On December 1 2020, Ziccum moved to Nasdaq First North Growth Market. Market. Ziccum focuses on …See details»
Ziccum launches new, expanded website
Dec 14, 2022 Ziccum CFO Frida Hjelmberg: “The whole Ziccum organization has contributed together in a strong collaboration with Chords. We are pleased that the site contains new …See details»
Ziccum (OM:ZICC) - Stock Price, News & Analysis - Simply Wall St
Nov 22, 2024 Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid …See details»
Ziccum AB (ZICC) Stock Price & News - Google Finance
Get the latest Ziccum AB (ZICC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»
Investors - Ziccum
Ziccum is developing LaminarPace®, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. By reducing drying stress to the active …See details»
ZICC Stock Price Quote - Morningstar
5 days ago See the latest Ziccum AB stock price (ZICC:XSTO), related news, valuation, dividends and more to help you make your investing decisions.See details»
Financial reports - Ziccum
Apr 15, 2024 Ziccum is developing LaminarPace®, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. By reducing …See details»